Non-Ras targets of farnesyltransferase inhibitors: Focus on Rho

Oncogene

Volumn 17, Issue 11 REV. ISS. 1, 1998, Pages 1439-1445

  Lebowitz, Peter F ^a   Prendergast, George C ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Apoptosis; Cell adhesion; Protein prenylation; Signal transduction; Transformation

Indexed keywords

PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN; RHO FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER THERAPY; CELL CYCLE; CELL SURVIVAL; CYTOLOGY; CYTOSTASIS; CYTOTOXICITY; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

ANIMALIA;

EID: 0032541625     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202175     Document Type: Review

References (51)

1. Adamson P, Marshall CJ, Hall A and Tilbrook PA. (1992). J. Biol. Chem., 267, 20033-20038.
2. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownlee M, Flynn E, Parangi S, Byers HR and Folkman J. (1997). Proc. Natl. Acad. Sci. USA, 94, 861-866.
3. Baichwal VR and Baeuerle PA. (1997). Curr. Biol., 7, R94-R96.
4. Barrington RE, Subler MA, Rands E, Omer CA, Miller PJ, Hundley JE, Koester SK, Troyer DA, Bearss DJ, Conner MW, Gibbs JB, Hamilton K, Koblan KS, Mosser SD, O'Neill TJ, Schaber MD, Senderak ET, Windle JJ, Oliff A, and Kohl NE. (1998). Mol. Cell. Biol., 18, 85-92.
5. Bar-Sagi D and Feramisco JR. (1986). Science, 233, 1061-1066.
6. Bobak D, Moorman J, Guanzon A, Gilmer L and Hahn C. (1997). Oncogene, 15, 2179-2189.
7. Casey PJ and Seabra MC. (1996). J. Biol. Chem., 271, 5289-5292.
8. Cox AD and Der CJ. (1992). Curr. Opin. Cell Biol., 4, 1008-1016.
9. Cox AD and Der CJ. (1997). Biochim. Biophys. Acta, 1333, F51-F71.
10. Cox AD, Garcia AM, Westwick JK, Kowalczyk JJ, Lewis MD, Brenner DA and Der CJ. (1994). J. Biol. Chem., 269, 1-4.
11. Cox AD, Hisaka MM, Buss JE and Der CJ. (1992). Mol. Cell. Biol., 12, 2606-2615.
12. Dalton MB, Fantle KS, Bechtold HA, DeMaio L, Evans RM, Krystosek A and Sinensky M. (1995). Cancer Res., 55, 3295-3304.
13. Farnsworth CC, Wolda SL, Gelb MH and Glomset JA. (1989). J. Biol. Chem., 264, 20422-20429.
14. Foster R, Hu KQ, Lu Y, Nolan KM, Thissen J and Settleman J. (1996). Mol. Cell. Biol., 16, 2689-2699.
15. Frisch SM and Ruoslahti E. (1997). Curr. Opin. Cell Biol., 9, 701-706.
16. Garcia AM, Rowell C, Ackermann K, Kowalczyk JJ and Lewis MD. (1993). J. Biol. Chem., 268, 18415-18418.
17. Gibbs J, Oliff A and Kohl NE. (1994). Cell, 77, 175-178.
18. Gibbs JB and Oliff A. (1997). Ann. Rev. Pharm. Tax., 37, 143-166.
19. Gibbs JB, Schaber MD, Schofield TL, Scolnick EM and Sigal IS. (1989). Proc. Natl. Acad. Sci. USA, 86, 6630-6634.
20. Graham SM, Vojtek AB, Huff SY, Cox AD, Clark GJ, Cooper JA and Der CJ. (1996). Mol. Cell. Biol., 16, 6132-6140.
21. Hall A. (1998). Science, 279, 509-514.
22. Hill CS, Wynne J and Treisman R. (1995). Cell, 81, 1159-1170.
23. Hotchin NA and Hall A. (1996). Cancer Surv., 27, 311-322.
24. Jahner D and Hunter T. (1991a). Mol. Cell. Biol., 11, 3682-3690.
25. Jahner D and Hunter T. (1991b). Oncogene, 6, 1259-1268.
26. James GL, Brown MS, Cobb MH and Goldstein JL. (1994). J. Biol. Chem., 269, 27705-27714.
27. James GL, Goldstein JL and Brown MS. (1995). J. Biol. Chem., 270, 6221-6226.
28. James GL, Goldstein JL, Brown MS, Rawson TE, Somers TC, McDowell RS, Crowley CW, Lucas BK, Levinson AD and Marsters JC. (1993). Science, 260, 1937-1942.
29. Jimenez B, Arends M, Esteve P, Pcrona R, Sanchez R, Cajal R, Wyllie A and Lacal JC. (1995). Oncogene, 10, 811-816.
30. Kato K, Cox AD, Hisaka MM, Graham SM, Buss JE and Der CJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 6403-6407.
31. Kohl NE, Mosser SD, deSolms SJ, Giuliani EA, Pompliano DL, Graham SL, Smith RL, Scolnick EM, Oliff A and Gibbs JB. (1993). Science, 260, 1934-1937.
32. Kohl NE, Omer CA, Conner MW, Anthony NJ, Davide JP, deSolms SJ, Giuliani EA, Gomez RP, Graham SL, Hamilton K, Handt LK, Hartman GD, Koblan KS, Krai AM, Miller PJ. et al. (1995). Nat. Med., 1, 792-797.
33. Khosravi-Far R, Solski PA, Clark GJ, Kinch MS and Der CJ. (1995). Mol. Cell. Biol., 15, 6443-6453.
34. Kohl NE, Redner F, Mosser S, Guiliani EA, deSolms SJ, Conner MW, Anthony NJ, Holtz WJ, Gomez RP, Lee T-J, Smith RL, Graham SL, Hartman GD, Gibbs J and Oliff A. (1994). Proc. Natl. Acad. Sci. USA, 91, 9141-9145.
35. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR and Reed JC. (1996). Cancer Res., 56, 2422-2427.
36. Lacal JC. (1997). FEBS Lett., 410, 73-77.
37. Larcher F, Robles AK, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ and Jorcano JL. (1996). Cancer Res., 56, 5391-5396.
38. Lebowitz P, Casey PJ, Prendergast GC and Thissen J. (1997a). J. Biol. Chem., 272, 15591-15594.
39. Lebowitz PF, Davide JP and Prendergast GC. (1995). Mol. Cell. Biol., 15, 6613-6622.
40. Lebowitz PF, Du W and Prendergast GC. (1997b). J. Biol. Chem., 212, 16093-16096.
41. Lebowitz PF, Sakamuro D and Prendergast GC. (1997c). Cancer Res., 57, 708-713.
42. Lebowitz PF and Prendergast GC. (1998). Cell Adhes. Comm., in press.
43. Leonard DM. (1997). J. Med. Chem., 40, 2971-2990.
44. Lerner EC, Zhang TT, Knowles DB, Qian YM, Hamilton AD and Sebti SM. (1997). Oncogene. 15, 1283-1288.
45. Manne V, Yan N, Carboni JM, Tuomari AV, Ricca CS, Brown JG, Andahazy ML, Schmidt RJ, Patel D, Zahler R, Weinmann R, Der CJ, Cox AD, Hunt JT, Gordon EM, Barbacid M and Scizinger BR. (1995). Oncogene. 10, 1763-1779.
46. Marshall C. (1993). Science, 259, 1865-1866.
47. Mazure NM, Chen EY, Laderoute KR and Giaccia AJ. (1997). Blood, 90, 3322-3331.
48. Miquel K, Pradines A, Sun J, Qian Y, Hamilton AD, Sebti SM and Favre G. (1997). Cancer Res., 57, 1846-1850.
49. Miyake M, Mizutani S, Koide H, and Kaziro Y. (1996). FEBS Lett., 378, 15-18.
50. Murphy D, Saffrich R, Grummt M, Gournier H, Rybin V, Rubino M, Auvinen P, Lütcke A, Parton RG and Zerial M. (1996). Nature, 384, 427-432.
51. Nagase T, Kawata S, Tamura S, Matsuda Y, Inui Y, Yamasaki E, Ishiguro H, Ito T, and Matsuzawa Y. (1996). Int. J. Cancer, 65, 620-626.